BioDlink Named “Emerging CDMO of the Year” at the 2026 Asia-Pacific Biopharma Excellence Awards

BioDlink has been named “Emerging CDMO of the Year” for its innovation in complex biologics and ADC development. The award recognizes its proprietary technology platforms, scalable manufacturing, and a proven quality system with over 100 audits completed. SUZHOU, China, March 13, 2026 /PRNewswire/ — BioDlink, an innovation-driven Contract Development and Manufacturing Organization (CDMO), today announced […]